Stella Pharma Corporation (TYO:4888)
Japan · Delayed Price · Currency is JPY 353.00
-10.00 (-2.75%)
Aug 27, 2026, 11:30 AM JST
Stella Pharma Market Cap
Stella Pharma has a market cap or net worth of 13.08 billion as of August 26, 2026. Its market cap has decreased by -6.03% in one year.
Market Cap
13.08B
Enterprise Value
10.18B
Revenue
323.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
353.00
ChartMarket Cap Chart
Since April 22, 2021, Stella Pharma's market cap has decreased from 23.73B to 13.08B, a decrease of -44.88%. That is a compound annual growth rate of -10.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2026 | 13.08B | 89.33% |
| Dec 30, 2025 | 6.91B | -62.20% |
| Dec 30, 2024 | 18.28B | 105.37% |
| Dec 29, 2023 | 8.90B | -22.42% |
| Dec 30, 2022 | 11.47B | -56.48% |
| Dec 30, 2021 | 26.35B | 11.06% |
| Apr 22, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AnGes | 15.55B |
| CanBas | 15.08B |
| ReproCELL | 14.69B |
| RaQualia Pharma | 14.40B |
| Kubota Pharmaceutical Holdings | 10.86B |
| Immuno-Biological Laboratories | 9.87B |
| SUSMED,Inc. | 9.68B |
| Nano Holdings | 9.39B |